A study titled "Effects of Mango and Mint Pod-based E-cigarette Aerosol Inhalation on Inflammatory Status of the Mouse Brain, Lung, Heart, and Colon" published in eLife has found that Juul aerosol exposure affects different organs of mice and analyses how specific e-cigarette flavors contribute to this effect.
In this research study, a team led by Dr. Laura Crotty Alexander, a medical professor and director of the ICU in the UC San Diego Health System and the VA San Diego Healthcare System, investigated the effects of aerosols produced by flavored electronic cigarettes (JUUL) on inflammatory biomarkers in the brain, lungs, heart, and colon. Participants in the study inhaled the aerosol three times a day for three months.
Crotty and her team also studied the effects of the most popular flavors of the brand: mint and mango. The researchers discovered several elevated inflammation markers, with the most significant being in the brain. They also found changes in gene expression within brain regions related to motivation and reward processing.
Analysis of colon samples showed an increase in the expression of inflammatory genes, which is associated with an increased risk of gastrointestinal diseases. Meanwhile, the inflammation levels in heart tissue seem to have lowered, leading the authors to suggest that this could indicate a suppression of the immune system.
E-cigarettes and heart health.
Researchers from Ohio State University's medical school recently published a study in the American Heart Association (AHA) journal, titled "E-cigarette aerosol impairs left ventricular function in adolescent mice.
According to a study, mice exposed to a mixture of electronic cigarette aerosols containing propylene glycol, vegetable glycerin, and nicotine from the equivalent of around 12 years old in humans until around 30 years old, experienced a decline in heart function in males over time. However, interestingly, there was no adverse effect observed in the heart function of female mice.
Statement:
This article is compiled from third-party information and is intended solely for industry exchange and learning.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is only for communication and research within the industry.
Due to limitations in the ability to translate, the translated article may not convey the exact meaning of the original text. Therefore, it is recommended to refer to the original text for accuracy.
2FIRSTS is completely aligned with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
